Impact of PharmaCloud on Pharmacist-Led Medication Reconciliation Efficiency and Error Detection Among Taiwanese Inpatients
Impact of Integrating PharmaCloud on Pharmacist-Led Medication Reconciliation Efficiency and Error Detection Among Internal Medicine Inpatients: A Prospective Non-Randomized Study in Taiwan
1 other identifier
interventional
93
1 country
1
Brief Summary
Taiwan's National Health Insurance Administration PharmaCloud provides cross-institutional medication access to reimbursed medication records to support best possible medication history (BPMH) compilation. However, its utility among internal medicine inpatients, who typically present with complex regimens and frequent medication changes, remains understudied. This study aims to evaluate the impact of PharmaCloud integration on pharmacist-led medication reconciliation (MedRec) efficiency and error detection among internal medicine inpatients at both admission and discharge. The non-randomized, single-center study was conducted from May to November 2024 at the Far Eastern Memorial Hospital in Taiwan. Internal medicine inpatients taking at least one pre-admission chronic medication were enrolled and assigned to standard medication reconciliation protocol (control) or PharmaCloud-integrated medication reconciliation (experimental). Best possible medication history compilation time was recorded across two stages: preparation and interview. Medication discrepancies were identified at admission and discharge and classified as intentional or unintentional.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedFirst Submitted
Initial submission to the registry
July 20, 2026
CompletedFirst Posted
Study publicly available on registry
July 27, 2026
CompletedJuly 27, 2026
July 1, 2026
7 months
July 20, 2026
July 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Best possible medication history compilation efficiency
The first outcome measure was best possible medication history (BPMH) compilation efficiency, which was measured in minutes as three metrics: preparation time (stage 1), measured from the start of electronic medical record (EMR) and PharmaCloud review to the completion of the preliminary BPMH; interview time (stage 2), measured from the start to the end of the face-to-face interview; and total BPMH compilation time, the sum of stage 1 and 2.
From patient's time of hospital admission to 72 hours post-admission.
Secondary Outcomes (1)
Medication error detection rate
Admission: Unintentional discrepancies identified from patient's time of admission to 72 hours post-admission. Discharge: Unintentional discrepancies identified immediately prior to patient's departure from the facility.
Study Arms (2)
Standard medication reconciliation
NO INTERVENTIONBest possible medication histories (BPMHs) were constructed within 72 hours of patient admission. First, designated pharmacists compiled a preliminary BPMH by reviewing in-house electronic medical records. Then, pharmacists conducted patient or caregiver interviews to form the finalized BPMH.
PharmaCloud-intergrated medication reconciliation
EXPERIMENTALBest possible medication histories (BPMHs) were constructed within 72 hours of patient admission. First, designated pharmacists compiled a preliminary BPMH by reviewing in-house electronic medical records and PharmaCloud data. Then, pharmacists conducted patient or caregiver interviews to form the finalized BPMH.
Interventions
The intervention entailed supplementing in-house electronic medical record with data from PharmaCloud, a platform launched by Taiwan's National Health Insurance Administration to enable cross-institutional access to reimbursed medication records.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Use of at least one pre-admission medication for a chronic disease
You may not qualify if:
- If patient was discharged within 48 hours of admission
- If patient was scheduled for surgery during their inpatient stay
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Far Eastern Memorial Hospital
New Taipei City, 220216, Taiwan
Related Publications (1)
Huang PP, Poon SY, Chang SH, Kuo CW, Chien MW, Chen CC, Chiang SC. Improving the Efficiency of Medication Reconciliation in Two Taiwanese Hospitals by Using the Taiwan National Health Insurance PharmaCloud Medication System. Int J Gen Med. 2023 Jan 19;16:211-220. doi: 10.2147/IJGM.S389683. eCollection 2023.
PMID: 36699342BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2026
First Posted
July 27, 2026
Study Start
May 1, 2024
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
July 27, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share